Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentrates

Haemophilia

Volumn 20, Issue 3, 2014, Pages 322-325

  Giangrande, P ^a,b   Seitz, R ^c   Behr Gross, M E ^d   Berger, K ^e   Hilger, A ^c   Klein, H ^f   Schramm, W ^g   Mannucci, P M ^h  

^a Oxford Haemophilia and Thrombosis Centre   (United Kingdom)

^b European Haemophilia Consortium   (Belgium)

^c PAUL EHRLICH INSTITUT   (Germany)

^d European Directorate for the Quality of Medicines and Health Care   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g Rudolf Marx Stiftung   (Germany)

^h FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Factor VIII; Guidelines; Haemophilia; Prophylaxis; Treatment

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE; ORPHAN DRUG; BLOOD CLOTTING FACTOR;

ARTICLE; BLEEDING DISORDER; CLINICAL DECISION MAKING; CONSENSUS; CONSULTATION; DISEASE SEVERITY; EUROPE; HEALTH CARE ORGANIZATION; HEMOPHILIA; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN MODIFICATION; TREATMENT OUTCOME; CHILD; CONSENSUS DEVELOPMENT; HEMOPHILIA A; PRACTICE GUIDELINE;

BLOOD COAGULATION FACTORS; CHILD; CONSENSUS; EUROPE; HEMOPHILIA A; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84898614378     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12440     Document Type: Article

References (9)

1. O'Mahony B, Noone D, Giangrande PL, Prihodova L. Haemophilia care in Europe - a survey of 35 countries. Haemophilia 2013; 19: e239-47.
2. European Symposium: Optimal use of clotting factors and immunoglobulins, 26-27 April 2013, Wildbad Kreuth, Germany. Proceedings Directorate for the Quality of Medicines & Healthcare of the Council of Europe (EDQM), Strasbourg, 2013. Available at https://www.edqm.eu/site/full_proceedings_kreuth_iiipdf-en-31291-2.html. (accessed April 1, 2014).
3. Mannucci PM. Back to the future: a recent history of haemophilia treatment. Haemophilia 2008; 14(Suppl. 3): 10-8.
4. Kaufman RJ, Powell JS. Molecular approaches for improved clotting factors for hemophilia. Blood 2013; 122: 3568-74.
5. Communication from the Commission to the Council, the European Parliament and the Economic and Social Committee on blood Self-Sufficiency in the European Community. [COM(93) 198 final Brussels, 25 May 1993 13p].
6. Department of Health, Ireland. Conclusions and Recommendations. Colloquium on Blood Safety and Self-Sufficiency: An Agenda for the European Community. County Limerick, Ireland: Adare, 4-6 September, 1996.
7. Schramm W, von Auer F, Delaney F, Seitz R Blood Safety in the European Community: An Initiative for Optimal Use. Wildbad Kreuth, 20-22 May, 1999. Conference Proceedings, ISBN 3-00-005705-6.
8. Berger K, Klein HG, Seitz R, Schramm W, Spieser JM. The Wildbad Kreuth initiative: European current practices and recommendations for optimal use of blood components. Biologicals 2011; 39: 189-93.
9. Schramm W, Gringeri A, Ljung R et al. Haemophilia care in Europe: the ESCHQoL study. Haemophilia 2012; 18: 729-37.